Biotechnology News

July 7, 2014

ROCKVILLE, Md.--(BUSINESS WIRE)--RegeneRx Pharmaceuticals (OTCBB:RGRX), and G-treeBNT Co. Ltd., a Korean biotech firm, jointly announced today that G-treeBNT is preparing to file an IND and sponsor a Phase III clinical trial with RGN-259 (a...

July 7, 2014

SAN DIEGO--(BUSINESS WIRE)--Cytori has received preliminary written notice of intent to exercise ‘Option 1’ of their contract with BARDA. Cytori will announce the contract details as soon as completed.

July 7, 2014

LAS VEGAS--(BUSINESS WIRE)--Medican Enterprises director, Gary Johnson, appointed CEO of Cannabis Sativa Inc. Johnson, two time governor of New Mexico was appointed to the Medican board of directors on January 23, 2014.

July 7, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that it plans to host and webcast a series of online “RNAi Roundtables” during July and August. Alnylam...

July 7, 2014

SAN DIEGO, Calif.--(BUSINESS WIRE)--La Jolla Pharmaceutical Company Strengthens Board of Directors with Appointment of Robert H. Rosen

July 7, 2014

SAN CARLOS, Calif. & NEW YORK--(BUSINESS WIRE)--Natera, Inc. and the Mount Sinai Genetic Testing Laboratory have entered into a partnership to offer an expanded Horizon™ genetic carrier screening test for prospective families. Genetic carrier...

July 7, 2014

TEL AVIV, Israel--(BUSINESS WIRE)--Compugen achieved the initial milestone in the cancer immunotherapy collaboration it entered with Bayer HealthCare for which Compugen will receive a $1.2 mill payment out of the $30 mill payments

July 7, 2014

PARSIPPANY, N.J. & ABANO TERME, Italy--(BUSINESS WIRE)--Fidia Completes Establishment of its Operations and Seeks Further Growth Opportunities in North America

July 7, 2014

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved Daklinza® (daclatasvir), a potent, pan-genotypic NS5A replication complex...

July 7, 2014

HENDERSON, Nev.--(BUSINESS WIRE)--FDA Grants Spectrum Pharmaceuticals Accelerated Approval of Beleodaq(TM) (belinostat) for Injection

July 7, 2014

SANTA CLARA, Calif.--(BUSINESS WIRE)--Affymetrix, Inc. (NASDAQ:AFFX) today announced that it will report operating results for the second quarter of 2014 after market close on Thursday July 31, 2014. The company will hold a conference call on the...

July 7, 2014

VILLEJUIF, France--(BUSINESS WIRE)--WIN welcomes Asan Medical Center (Korea), Cambridge Cancer Center (UK), Cancer Research UK (UK), CEO Roundtable on Cancer (USA), Jefferson Kimmel Cancer Center (USA), Memorial Sloan Kettering (USA).

July 7, 2014

LUND, Sweden--(BUSINESS WIRE)--Regulatory News: BioInvent (STO:BINV) BioInvent International (OMXS: BINV) today announced that it has received two separate milestone payments, together worth 1 MEuro, as a result of milestones being reached under...

July 7, 2014

STOCKHOLM--(BUSINESS WIRE)--Regulatory News: Bactiguard Holding (STO:BACTIB) Bactiguard establishes market presence in Southern Africa and has entered into exclusive distribution agreements, covering seven sub-Saharan countries and Bactiguard’s...

July 4, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (NYSE:TEVA) today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion in a referral procedure...

July 3, 2014

MORRISTOWN, N.J.--(BUSINESS WIRE)--QPharma, a leading regulatory compliance and brand solutions company, has expanded its call center offerings with the addition of an Aggregate Spend Call Center solution for life sciences companies. “As...

July 3, 2014

PARIS--(BUSINESS WIRE)--Regulatory News: BioAlliance Pharma SA (Paris:BIO), an innovative Company specialized in the development of drugs in orphan oncology diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted...

July 3, 2014

EVRY, France & MUNICH--(BUSINESS WIRE)--Regulatory News: Global Bioenergies (Paris:ALGBE) (Alternext Paris : ALGBE) and the Fraunhofer Center for Chemical-Biotechnological Processes announced today that they have signed the contract for the...

July 3, 2014

MEMPHIS, Tenn.--(BUSINESS WIRE)--MicroPort Orthopedics Inc. (“MPO”) and MB Innovations (“MBI”) announced today that the two firms have entered into a multi-product development agreement for orthopedic instruments. MBI will initially provide...

July 3, 2014

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Advanced Cell Technology, Inc. (“ACT”)(OTCBB:ACTC), a leader in the field of regenerative medicine, today announced that it has entered into a $30 million common stock purchase agreement with Lincoln Park...

July 3, 2014

CLARENCE, N.Y.--(BUSINESS WIRE)--22nd Century Group (NYSE MKT: XXII) announced today that the U.S. Patent and Trademark Office has issued a Notice of Allowance for technology that decreases or increases nicotine in tobacco plants.

July 3, 2014

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that the Company has filed a citizen petition (CP) regarding the approvability of purported generic versions of COPAXONE®. Teva submitted this CP...

July 3, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus expects to file its 10-Q for the 3rd quarter of fiscal year 2014 on Tuesday, July 8. A conference call to discuss the company's performance is scheduled for 1:15pm PT/4:15pm ET.

July 3, 2014

EMERYVILLE, Calif.--(BUSINESS WIRE)--NovaBay® Pharmaceuticals, Inc. (NYSE MKT: NBY), a biopharmaceutical company focusing on non-antibiotic anti-infectives, announced today that CEOLIVE.TV, an online service that delivers news about companies to...

July 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akashi announced that the Muscular Dystrophy Association has made an investment as part of a collective funding totaling $1.5 million to help fund clinical development of HT-100 for DMD.

July 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akashi Therapeutics announced that the FDA has granted Fast Track designation to the company’s most advanced product candidate, HT-100, for Duchenne muscular dystrophy (DMD).

July 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akashi Therapeutics presented preliminary positive clinical data for HT-100 for Duchenne muscular dystrophy (DMD) at the New Directions in Biology and Disease of Skeletal Muscle Conference.

July 3, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Lando and Anastasi, LLP (L&A) today announced that Cristin D. Berkey, Nathan A. Billings, Crystal Lee Kellas, and Angelyn Larkin have joined the firm. The Cambridge-based intellectual property law firm, one...

July 3, 2014

DARMSTADT, Germany--(BUSINESS WIRE)--Strong growth at Merck’s Consumer Health Division builds on 80 years of delivery

July 3, 2014

SAN DIEGO--(BUSINESS WIRE)--Batu Biologics announced today the appointment of Dr. Alan Lewis to the company’s Scientific Advisory Board, an experienced industry veteran with over 37 years of experience as an executive in life sciences. Dr. Lewis...

July 2, 2014

SALT LAKE CITY--(BUSINESS WIRE)--“Rich McKeown brings a deep understanding of the healthcare industry as the chief executive of one of the nation’s most respected healthcare consulting firms,” said ProLung President and CEO Steven Eror when he...

July 2, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea will host a webcast of an investor briefing to discuss the role of sentinel lymph node biopsy in head and neck cancers on Tuesday, July 8, 2014 with a guest speaker, Dr. Stephen Lai.

July 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Bind Therapeutics announced today the completion of its collaborative research program with Amgen Inc. originally entered into in January 2013.

July 2, 2014

LAUSANNE, Switzerland--(BUSINESS WIRE)--U.S. Food & Drug Administration grants Orphan Drug Designation for Galderma’s trifarotene molecule in the treatment of congenital ichthyosis.

July 2, 2014

IRVING, Texas--(BUSINESS WIRE)--Two hundred twenty tons of new hope for cancer patients came to North Texas early today with the arrival of the massive cyclotron at the Texas Center for Proton Therapy. The center, a collaboration of Texas...

July 2, 2014

WASHINGTON--(BUSINESS WIRE)--A new optical system based on a commercial video projector, a single pixel sensor and a signal processing technique called compressive sensing is a first step toward enabling deeper tissue imaging.

July 2, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Histogenics Corporation, a regenerative medicine company focused on developing and commercializing products in the musculoskeletal space, today announced the appointment of Kathleen Large, R.N., M.S., to Vice...

July 2, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the second quarter 2014 before the market opens on Wednesday, July 23, 2014...

July 2, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Synchroneuron closes $20 million Series B funding round from sole-investor Morningside Technology Ventures Limited to support the continued development of Phase 2 asset SNC-102.

July 2, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the election of Amy W. Schulman to its Board of Directors. Ms. Schulman is the former Executive Vice President...

July 2, 2014

CINCINNATI--(BUSINESS WIRE)--Ethicon Endo-Surgery (Ethicon) today announced the receipt of a Bronze International Design Excellence Awards (IDEA) from the Industrial Designers Society of America (IDSA) for innovation with ENSEAL® G2 Articulating...

July 2, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus today announced that the U.S. Environmental Protection Agency purchased five additional licenses of the Company's industry-leading GastroPlus and ADMET Predictor software programs.

July 2, 2014

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (NASDAQ:TBIO), a global biotechnology company advancing personalized medicine in cardiology, oncology, and inherited diseases through advanced diagnostic tests and clinical and research services,...